John Conley is listed as a director on 22 SEC Form D filings by 2 issuers between Feb 2011 and Nov 2023: Windgap Medical, Inc. (Watertown, MA — pharmaceuticals — 2014–2023; $39.2M reported sold to 114 investors) and Tarpon Biosystems Inc. (Worcester, MA — biotechnology — 2011–2014; $1.43M reported sold to 17 investors).
What this means 2 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $40.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 22 public filings for John Conley and found 15 differences, 2 worth asking the sponsor about: Investor count went down between filings; John Conley is no longer listed on the Jan 26, 2026 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.